LimFlow On Target For 2021 US Launch Of Deep Vein Arterialization System

 
• By Reed Miller

The results from the PROMISE I feasibility study give LimFlow confidence that the PROMISE II pivotal trial will prove that the LimFlow percutaneous deep vein arterialization system is a safe and effective alternative to amputation for patients with critical limb ischemia.

Lim Flow Crossings Stent Deploy Full
The LimFlow system diverts blood from the diseased artery into the tibial vein • Source: LimFlow, Inc.

More from Clinical Trials

More from R&D